Literature DB >> 16330636

Smart regulation: will the government's strategy work?

Janice Graham1.   

Abstract

Mesh：

Year:  2005        PMID： 16330636      PMCID： PMC1316163          DOI： 10.1503/cmaj.050424

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

2.  The safety of new medicines: the importance of asking the right questions.

Authors:  A J Wood
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

3.  Drug withdrawals from the Canadian market for safety reasons, 1963-2004.

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2005-03-15       Impact factor: 8.262

4.  What ails the FDA?

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

5.  How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Ken Bassett; Joel Lexchin; Arminée Kazanjian; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262
  5 in total
  1 in total

1.  From sandbox to pandemic: Agile reform of Canadian drug regulation.

Authors:  Ipek Eren Vural; Matthew Herder; Janice E Graham
Journal:  Health Policy       Date:  2021-05-15       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.